daily oral glp-1 receptor agonist orforglipron for adults with obesity Shows Positive Efficacy, Tolerability in Weight Management Orforglipron: What Toxicologists Should Be

Appetite suppression requires higher receptor occupancy than these doses provide

Lower concentrations excel at precision for small doses but struggle with volume at higher doses

The beneficial effects of GLP-1 receptor activation on glycemia occur through several mechanisms: GLP-1 stimulates glucose-dependent insulin secretion from pancreatic -cells, suppresses inappropriately elevated glucagon secretion from pancreatic -cells, delays gastric emptying, and induces satiety via a direct action in the central nervous system

These agents act on multiple physiological pathways involved in type 2 diabetes with the effect of increasing insulin secretion and decreasing glucagon to control glucose levels (1,2)

Akt, FoxO and regulation of apoptosis